Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
|
Ipsogen Expands its US Market Presence Through Licensing Agreement With ARUP Laboratories for the Commercialization of JAK2 Molecular Diagnostic AssaysMonday 4th of May 2009 2:30BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
 Browse other news from this organisation: Ipsogen SA Related Web-Links(If any, Generated Automatically)
Source PR Newswire  |
|
Nothing in this website should be used in
place of personal medical advice from your own qualified medical
practitioner. |
All rights reserved. All other trademarks recognized. |
|
